Objective. Knowledge about the range of symptoms experienced by patients with SSc, and their impact on daily functioning is limited. The objective of the present study was to identify symptoms of SSc that patients rated as frequent and that highly impacted their ability to carry out daily activities.
Introduction
SSc, or scleroderma, is a chronic, multi-system, connective tissue disorder characterized by thickening and fibrosis of the skin, involvement of internal organs, and substantially reduced functional ability and quality of life (QoL) [13] . Patients with SSc report a number of problems associated with disability and reduced QoL, including gastrointestinal problems, difficulty breathing, pain from various sources, depression, fatigue and pruritus [411] . Due to the rarity and heterogeneity of the disease, however, not enough is known about the frequency and perceived impact of the range of problems faced by individuals living with SSc. There is also a lack of consensus on which problems should be the focus of research. Whereas physicians may prioritize objective indicators of disease status, patients may perceive other aspects of their disease experience as more debilitating or distressing [12] .
Several existing studies have assessed the degree to which specific SSc symptoms are prevalent, annoying or burdensome to patients [1214] . van Lankveld et al. [13] administered an 18-item disease-related stressors questionnaire to 123 Dutch SSc patients using a 4-point Likert scale ranging from not annoying at all to very annoying and reported that fatigue, functional limitations, skin deformities, pain and disfigurement were among the most annoying symptoms. Richards et al. [14] assessed 14 symptoms among 49 patients in the UK and found that stiff joints, pain and fatigue were most commonly associated with SSc. Suarez-Almazor et al. [12] conducted focus groups with 19 patients in the USA and identified physical pain, coping skills, social aspects of living with the disease, physical appearance and patientphysician relationships as particularly important to patients. However, knowledge about the range of problems experienced by patients with SSc, and the relative importance of different problems, is limited by the small number of existing studies, the relatively narrow range of potential problems assessed in these studies and the small number of patients included in each study.
The Canadian Scleroderma Patient Survey of Health Concerns and Research Priorities was developed jointly by patients and researchers in order to assess topics of potential importance to patients that may currently be under-researched. The survey encompassed a wide range of topics, including health care accessibility and satisfaction, financial and employment implications of living with SSc and disease symptomatology. The objective of this study was to identify symptoms of SSc rated by patients as frequent or high impact in terms of reduced ability to carry out daily activities, in a large Canadian sample of persons with SSc.
Patients and methods

Patient sample
Persons with SSc were recruited to complete the anonymous survey from September 2008 to August 2009. The survey was publicized with a presentation at the annual meeting of the Scleroderma Society of Canada in September 2008; via notices posted on the web sites of the Scleroderma Society of Canada and Sclé rodermie Qué bec; in full-page advertisements in Canadian magazines in English (McLean's) and French (l'Actualité ); by announcements in Canadian national and provincial scleroderma-related newsletters; by contact with members of support groups across Canada by chapter leaders; and with promotional materials that were distributed in offices of physicians affiliated with the Canadian Scleroderma Research Group. Patients were able to complete the survey in English or French online using Survey Monkey, an easy to use web-based survey tool, or by requesting a paper copy. To be included in data analyses for the present study, survey respondents were required to be at least 18 years old, to have reported being diagnosed with SSc by a physician and to be a resident of Canada. In addition, patients who failed to complete 510% of survey items on symptom frequency and severity (14 of [1216] were examined before creating the survey to ensure that the survey addressed as many potentially significant issues as possible. Prior surveys created by the Arthritis Society were consulted, including the Listening to Patients Survey [17] and the CARE III online patient survey [18] . In addition, a panel of clinicians, researchers and patients was consulted to develop survey sections and items and to provide feedback in order to refine and modify the survey. Drafts of the survey were piloted for content and structure by 25 Scleroderma Society of Canada patient members from across Canada.
A list of 69 symptom items was generated. Patients were asked to rate the frequency and impact of each symptom. The frequency questions were worded 'How frequently have you experienced (insert symptom) in the past year?' with the response options never, rarely, sometimes, most of the time and always. To determine the impact, participants were asked to 'Please specify the degree of impact that (insert symptom) has had on your ability to carry out everyday activities in the past year', with the response options no impact, minimal, moderate, severe and extremely severe. When frequency was rated never, impact was automatically coded no impact.
Data analyses
Symptom frequency and impact were recoded into dichotomous variables. With respect to frequency, responses were coded never or rarely vs sometimes, most of the time or always. For impact, responses were coded no impact or minimal impact vs moderate, severe or extremely severe impact. We performed a descriptive analysis of the frequency of symptoms rated as at least some of the time and symptom impact on daily activities rated as at least moderate. In addition, for each item, among patients with frequency of at least sometimes, the percentage of patients with at least moderate impact was calculated. For items on vaginal dryness and erectile dysfunction, only responses from women and men, respectively, were tabulated.
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Frequency and impact of symptoms in SSc Results
Sample characteristics
A total of 856 surveys were completed, 669 (78%) online and 187 (22%) using the paper version. Of these, 64 (7%) were classified as likely duplicates, based on matching demographic data. This generally occurred when respondents began the online survey, submitted part of it and subsequently started again. Of the 792 unique persons who completed all or part of the survey, 153 (19%) were not eligible because the respondent did not report a diagnosis of SSc by a specific health care provider (e.g. rheumatologist, dermatologist), including 36 respondents with linear scleroderma or morphoea; 8 (1%) were not eligible because the respondent was <18 years of age; 38 (5%) were not eligible because the respondent was not from Canada. Of the 603 potentially eligible surveys, 139 (23%) were excluded because patients completed <10% of symptom items. A total of 464 respondents were included in analyses.
Demographic characteristics of the present sample are presented in Table 1 . Most respondents were females (88%), white (72%), primarily English speaking (77%), married (72%) and had at least a high school education (89%). The mean age was 56 years, and the mean time since diagnosis of SSc was 11 years. Approximately half of respondents reported that they had diffuse (13%) or limited (36%) SSc, whereas half (50%) did not know their disease subtype classification.
Symptom frequency and impact on daily activities
Frequency and impact on daily activities for each symptom are shown in Table 2 . The five most frequently experienced symptoms, all of which were endorsed by >75% of respondents, included fatigue (89%), RP (86%), hand stiffness (81%), joint pain (81%) and difficulty sleeping (76%). Symptoms related to pain and discomfort, including skin tightening (72%), muscle pain (71%) and tender joints (71%) were also endorsed by at least 70% of the respondents. In addition to hand stiffness, two other items related to the hands were endorsed at very high rates, difficulty making a fist (67%) and difficulty holding objects (67%).
The symptoms that were most frequently experienced also tended to be the symptoms that had at least moderate impact on daily activities. Several symptoms, however, were highly ranked in terms of frequency, but rated much lower in terms of impact, including itching, which was the 9th most frequently experienced, but 31st in terms of impact, dry mouth (13th vs 27th) and skin colour change (15th vs 42nd). On the other hand, open sores was ranked 55th in terms of frequency, but 32nd in terms of the number of patients with at least moderate impact.
Problems associated with SSc that had at least moderate impact among 575% of patients who experienced them at least some of the time were kidney failure (100%), open sores (95%), blood clots (92%), finger ulcers (91%), migraines (87%), difficulty walking (84%), fainting (84%), stool incontinence (82%), fatigue (81%), swollen joints (80%), joint pain (79%), difficulty washing (79%), RP (78%), difficulty sleeping (78%), muscle pain (77%), side effects of medications (77%), fever (76%), difficulty holding objects (76%), difficulty opening hands (75%), shortness of breath (75%), carpal tunnel syndrome (75%) and liver inflammation (75%).
Discussion
The symptoms with the highest frequency, which were also the most likely to have at least moderate impact on daily activities were fatigue, RP, stiff hands, joint pain and difficulty sleeping. Previous studies have reported that patients with SSc have higher levels of fatigue and pain than the general population, with levels comparable to those of patients with other rheumatic diseases [46] . Contractures and deformities of the hand, consisting of decreased flexion and limited extension as well as reduced thumb abduction, are common and contribute substantially to disability in SSc [19] . The only study that has investigated sleep problems in SSc found that 19 (70%) of 27 people had reduced sleep efficiency compared with age-adjusted norms [20] . Patients also reported a number of other problem symptoms at relatively high rates or impact, some of which have not been the subject of focused research. There are limitations that should be considered in interpreting the results of this study. Primarily, the study used a convenience sample of survey respondents and relied upon self-report of a diagnosis of SSc by a health care provider, the reliability of which is not known. Recruitment methods included physicians involved in the Canadian Scleroderma Research Group, support groups and patient advocacy groups, which may have influenced the representativeness of the sample. In addition, a large portion of the survey dissemination and response was electronic (newsletters, web sites and the online survey itself), which may have influenced the characteristics of respondents. On the other hand, whereas all of the patients in the Canadian Scleroderma Research Group Registry and most other academic cohorts are seen by a rheumatologist, only 63% of survey respondents listed a rheumatologist as the health care professional who primarily cared for their disease, which may be more representative of patients with SSc. Approximately half of the patients did not know their SSc subtype, likely because physicians often do not use this terminology with patients. Therefore, we were unable to explore possible differences between limited and diffuse SSc. Patients tended to have long disease duration and, of patients who reported a diagnosis, most had limited SSc. Patients with early stage disease or diffuse SSc may have different problems. Other limitations of this study include the single-item assessment of symptoms, the lack of precise medical information due to the self-report nature of the survey and the non-inclusion of mental health problems in the symptom list.
In summary, this is the first study to assess the frequency and impact of such a broad range of problems experienced by a large number of people living with SSc. A strength of this study is that the protocol was developed collaboratively by patients and researchers with extensive experience in SSc. Collaborative, multi-centre, multi-disciplinary efforts that involve patients and patient advocates are crucial to better understand the nature of problems that impact QoL in SSc and to develop successful interventions to improve QoL and well-being for people living with SSc.
Rheumatology key messages
. Knowledge about the range of problems experienced by patients with SSc is limited. . Common, high-impact problems include fatigue, RP, hand problems, joint pain and difficulty sleeping. . Research on care for important, understudied problems, including fatigue, hand and sleep problems is needed.
